Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd.
PAR · ASX

Paradigm Biopharmaceuticals Ltd.

AU$0.34

0.00 (0.00%)
02/01/2026 04:10:12 PM
All-CompaniesAll-ConsensusGROWTH AUSHALO Consensus ValueHALO Ords
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Paradigm Biopharmaceuticals Ltd. Overview

PAR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About PAR

icon

Telephone

61.3.9629.5566

icon

Address

Level 15, 500 Collins Street, Melbourne, Victoria (VIC) 3000

Description

Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. It is a drug repurposing company which seeks to find new uses for old drugs. The company was founded by Paul John Rennie on May 2, 2014 and is headquartered in Melbourne, Australia.

PAR Price Chart

Key Stats

Market Cap

AU$145.70M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.25 - 0.66

Trade Value (12mth)

AU$111,140.00

1 week

0%

1 month

-2.86%

YTD

N/A

1 year

-17.07%

All time high

4.35

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

-$16m

Free Cash Flow Return

-70.90%

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares Outstanding (Fully Diluted)

389m

HALO Sector

Healthcare

Next Company Report Date

21-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

PAR Announcements

Latest Announcements

DateAnnouncements
23 December 25
19 November 25
19 November 25
17 November 25
17 November 25

PAR Fundamentals

Per Share Records

Historical data

Forecast data

AUD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.18-0.2-0.06locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.18-0.2-0.06locklocklock
Growth
%locklocklocklock-10-11.670.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

0.11%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PAR Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Paradigm Biopharmaceuticals Ltd. (PAR:ASX)?
Halo FAQ
The current share price of Paradigm Biopharmaceuticals Ltd. (PAR:ASX) is AUD$0.34.
What is the 52-week high share price for Paradigm Biopharmaceuticals Ltd. (PAR:ASX)?
Halo FAQ
The 52-week high share price for Paradigm Biopharmaceuticals Ltd. (PAR:ASX) is AUD$0.66.
What is the 52-week low share price for Paradigm Biopharmaceuticals Ltd. (PAR:ASX)?
Halo FAQ
The 52-week low share price for Paradigm Biopharmaceuticals Ltd. (PAR:ASX) is AUD$0.25.
What is the dividend yield for Paradigm Biopharmaceuticals Ltd. (PAR:ASX)?
Halo FAQ
Paradigm Biopharmaceuticals Ltd. (PAR:ASX) does not pay a dividend.
What was Paradigm Biopharmaceuticals Ltd. (PAR:ASX) last dividend payment?
Halo FAQ
Paradigm Biopharmaceuticals Ltd. (PAR:ASX) does not pay a dividend.
What is the franking level for Paradigm Biopharmaceuticals Ltd. (PAR:ASX)?
Halo FAQ
Paradigm Biopharmaceuticals Ltd. (PAR:ASX) has a franking level of 0.00%.
In which sector is Paradigm Biopharmaceuticals Ltd. (PAR:ASX) classified?
Halo FAQ
Paradigm Biopharmaceuticals Ltd. (PAR:ASX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.